Tag Archives: Drug trial

Vaccine maker ETF rises to Trump’s positive proclamation

Vaccine makers were climbing during Thursday’s volatile market session when investors took President Trump’s bullish proclamation on Wednesday that a vaccine to treat COVID-19 is closer than many expected to hear. Inovio Pharmaceuticals (INO) – Get report jumped more than 17% on Thursday, while Sorrento (SRNE) – Get report Almost …

Read More »